Phase Ii Study Of Gemcitabine (G) And Bevacizumab (B) As First-Line Treatment In Taxane-Pretreated, Her2-Negative, Locally Recyrrent Or Metastatic Breast Cancer (Mbc): Interim Safety Analysis
JOURNAL OF CLINICAL ONCOLOGY（2010）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要